Search is Powered by Google
Breast Cancer News

Research Projects Focus On Breast, Cervical Cancer Risk Among Women Living On U.S.-Mexico Border

Main Category: Breast Cancer
Also Included In: Cervical Cancer / HPV Vaccine
Article Date: 10 Jan 2008 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Researchers in New Mexico are looking into increased risk of breast and cervical cancers for women living along the New Mexico-Mexico border, the Las Cruces Sun-News reports.

John Moraros of the New Mexico State University Department of Health Science, said, "Hispanic women on the U.S.-Mexico border are more likely to die of cervical cancer and breast cancer than women who live elsewhere in the U.S. or Mexico. Low participation by Latinas in early detection screening programs is a serious problem. That puts women at risk because often the diseases aren't diagnosed until they are very advanced and treatment options are less effective."

Moraros is studying cervical cancer, while his wife, Yelena Bird, is looking into breast cancer under a grant from the Center for Border Health Research. He is analyzing the DNA of the human papillomavirus to determine which types of infection are most common in southern New Mexico and the northern Chihuahua border. A report by Moraros said, "Research has demonstrated that cervical cancer is caused by a sexually transmitted infection involving the human papilloma virus. About 10% of the women on the border have abnormal Pap smears and of this number, 10% have HPV that, if left untreated, can lead to cancer."

Hugo Vilchis, director of New Mexico State University's Border Epidemiology and Environmental Health Center, is conducting a study to determine whether promotoras, or health promoters, can increase the number of Hispanic women receiving Pap tests and following up on abnormal results. Vilchis said, "We will teach between six and eight promotoras basic information about Pap smears. We will prepare materials for them that they can use to teach Hispanic women between 21 and 65 years old about the importance of getting Pap smears. And the promotoras will play the role of extended family member, helping the women get to their doctors."

According to Vilchis, "In the Latin American culture, it's important for women in particular to have company with them when they go to the doctors. Family or extended family support is very important. But some women may have nobody to accompany them, so they won't go to the doctor." Vilchis' research is one of several projects funded by a five-year, National Cancer Institute grant (Moore, Las Cruces Sun-News, 1/9).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
18 Jul 2008
A large study published in The Lancet Oncology has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...